Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias - Trial NCT05964660
Access comprehensive clinical trial information for NCT05964660 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Luebeck and is currently Not yet recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University of Luebeck
Timeline & Enrollment
N/A
Aug 01, 2023
Jun 01, 2024
Primary Outcome
Feasibility of algorithm training to achieve improved arrhythmogenic substrate characterization,Feasibility of algorithm training to improve the planning target volume definition for stereotactic arrhythmia radioablation therapy
Summary
Prospective, observational, single center, pilot study to analyze the feasibility of motion
 and structural data integration in patients with ventricular arrhythmia by means of
 artificial intelligence for improved arrhythmogenic substrate characterization and motion
 management during stereotactic arrhythmia radioablation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05964660
Non-Device Trial